Skip to main content

Juan Manuel Pericàs Pulido

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Juan Manuel Pericàs Pulido

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria Buti Ferret, Montserrat Gomez Perez, Judit Romero Vico, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Malalties hepàtiques, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

StopALD

IP: Meritxell Ventura Cots
Collaborators: Alba Maria Jiménez Masip, Juan Manuel Pericàs Pulido, Sonia Carramiñana Mayor, Juan Bañares Sanchez
Funding agency: Ajuntament Barcelona
Funding: 119700
Reference: AJUNT.BCN/CIENCIA_INNOV/2022/VENTURA
Duration: 08/12/2022 - 07/06/2024

EU Patient- cEntric clinicAl tRial pLatform - EU PEARL.

IP: Joan Genescà Ferrer
Collaborators: Santiago Pérez Hoyos, Anna Sanjuan Viaplana, Xavier Cañas Perea, Juan Espinosa Pereiro, Juan Manuel Pericàs Pulido, José Antonio Ramos Quiroga, Israel Molina Romero, Alex Sánchez Pla, Inmaculada Fuentes Camps, Adrián Sánchez Montalvá, Pol Ibañez Jimenez, Olga Sánchez- Maroto Carrizo, Gara Arteaga Henriquez, EU Patient- cEntric clinicAl tRial pLatform - EU PEARL., Alba Maria Jiménez Masip, Albert Barberà LLuis
Funding agency: The Innovative Medicines Initiative
Funding: 1987375
Reference: EU-PEARL_H2020_IMI2-2018
Duration: 01/11/2019 - 30/04/2023

Screening for liver fibrosis - population-based study across European countries

IP: Juan Manuel Pericàs Pulido
Collaborators: Joan Genescà Ferrer, Maria Francesca Cortese, Laura Puente Ramo, Alba Maria Jiménez Masip, Juan Bañares Sanchez
Funding agency: EUROPEAN COMMISSION
Funding: 172385.95
Reference: LIVERSCREEN_H2020SC1BHC2019
Duration: 01/01/2020 - 30/06/2025

Related news

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Betina Biagetti Biagetti

Betina Biagetti Biagetti

Diabetes and Metabolism
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more
Joana Ramis Garcia

Joana Ramis Garcia

Research technician
Pharmacokinetic Nanoparticles
Read more
Adrià  Tomé Cabello

Adrià Tomé Cabello

Medium Grade Technician
Technological Infrastructure Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.